Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe three licensed injection sites for Mounjaro are the abdomen, the thigh, and the upper arm — and evidence from the prescribing guidance shows all three are clinically effective when used correctly. The site you choose matters less than how you rotate between them. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber decides whether it's right for you before treatment begins, and they or your Patient Information Leaflet are always your first port of call for personalised injection technique guidance. That said, understanding the practical differences between sites helps you build a confident, consistent routine from your very first pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people starting Mounjaro quickly realise there isn't one universally "best" site, there's the site that works best for them, given their body, their lifestyle, and how steady their hand feels at 8am on a Tuesday. The licensed guidance (detailed in the NHS tirzepatide medicines page) confirms that the abdomen, thigh, and upper arm are all appropriate; the clinical priority is choosing a site you can reach easily, inject into consistently, and rotate reliably.
The abdomen is where most self-injectors start. There is usually a generous area of subcutaneous tissue, the site is straightforward to reach without twisting, and you can see what you're doing. Pick a spot at least two finger-widths away from the navel, skin near the belly button tends to be firmer, which can make the injection less comfortable.
The thigh is an excellent alternative, particularly if you're injecting while seated. Use the outer or front surface of the upper thigh, avoiding the inner thigh where skin folds and friction can cause irritation. If you want a closer look at how each of these options compares in practice, the page on the most effective place to inject Mounjaro weighs up the sites in more detail. The upper arm is convenient if someone else is helping with your injection; reaching a clean, unpinched spot on your own outer upper arm while holding the pen steady is genuinely tricky, so most people keep this for occasions when they have assistance.
A quick habit worth building in under a minute: before each injection, run a fingertip over the planned spot. If you feel any firmness, lumpiness, or tenderness compared with the skin around it, move your next point a couple of centimetres away. That thirty-second check catches developing injection-site reactions early, before they affect how smoothly the medicine is absorbed.
Rotating your injection site isn't just a comfort measure, it's a clinical one. Injecting repeatedly into the same patch of skin causes lipohypertrophy: a build-up of fibrous fatty tissue that forms under the surface. Absorbed medicine from these areas can be erratic, which undermines the steady, week-on-week consistency Mounjaro is designed to deliver.
A simple rotation system helps. Think of your abdomen as a clock face, and move one position clockwise each week. If you're using the thigh, alternate left and right. Keep a note in your phone, or use a small weekly sticker if that feels less fussy, the method doesn't matter, the principle does. For more detail on what a weekly rotation schedule looks like in practice, the guidance on Mounjaro injection sites walks through it clearly.
Also worth knowing: Mounjaro must not be injected into muscle or directly into a vein. The medicine is formulated for the subcutaneous layer, the layer of fatty tissue just beneath the skin. If you're lean and finding it difficult to create a skin fold, discuss this with your prescriber; there are technique adjustments that can help.
Side effects at the injection site (mild redness, itching, or a small raised area) are common when starting treatment. They usually settle within a day or two. Persistent swelling, pain, or hard nodules are worth flagging; your prescriber or aftercare team can advise. You can read about the broader range of side effects associated with Mounjaro injections if you want to know what to expect more generally.
Site selection sits alongside a handful of other technique factors that influence how consistently the medicine is delivered. Temperature matters: the pen should be used at room temperature, not taken straight from the fridge. Give it the time recommended in your Patient Information Leaflet to warm up, a cold pen is more uncomfortable and the KwikPen mechanism can feel stiffer. The exact room-temperature window is specified in the leaflet; always follow that rather than an estimate from any online source.
Skin preparation is straightforward. Clean the injection area with soap and water or an alcohol swab, then let the skin dry completely before injecting, pressing a damp swab is uncomfortable and can introduce moisture that irritates the site. Medical-grade alcohol swabs are easy to keep stocked for this.
Pinching technique applies mostly to leaner patients or the thigh: lift a small fold of skin gently, inject at the angle your pen is designed for (the Mounjaro KwikPen auto-inserts the needle), and hold the pen in place until you hear the click sequence finish. Withdrawing too early can mean part of the dose is lost. If you're unsure about counting clicks, the guide on how to count the Mounjaro KwikPen clicks covers the full sequence.
Finally, exercise near the injection site affects local blood flow, which can alter absorption timing. Many people prefer to inject the abdomen on a rest day and avoid intense abdominal exercise for a couple of hours after injecting. This is a practical preference rather than a hard clinical rule, but it's the kind of detail that makes the weekly routine feel less variable. For a full overview of how Mounjaro works and what to expect across a treatment course, the Mounjaro treatment page is a good starting point.
The Mounjaro KwikPen uses a built-in concealed needle, so you don't select needle length yourself, that part of the decision is already made for you by the pen's design. What you do control is making sure the pen is used correctly each time: cap removed, pen held flat against the skin at the right angle, plunger fully depressed until the injection is complete.
Used pens and needles must be disposed of safely. A properly sealed sharps container is the correct method; never re-sheath a needle or place used pens in household rubbish. Your local council or pharmacy can advise on sharps disposal collection in your area.
Questions about injection frequency sometimes come up alongside technique queries. Mounjaro is a once-weekly injection; if you're unsure about timing or what happens if a dose is delayed, that's a conversation for your prescriber rather than a self-adjustment. The guide on Mounjaro injection frequency explains the schedule clearly.
If you're considering starting Mounjaro and want to understand whether it's clinically suitable for you, check your eligibility with our prescribers, the consultation is free, and a real clinician reviews your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.